The Motley Fool, founded in 1993 by brothers David and Tom Gardner, is a multimedia financial services company dedicated to empowering individual investors with accessible, actionable advice. Headquartered in Alexandria, Virginia, the company offers a range of products, including stock recommendations, investment research, and personal finance guidance, through its popular website, newsletters, podcasts, and premium subscription services.
Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk Viking Therapeutics aspires to take market share from both Eli Lilly and Novo Nordisk, and it might succeed.
What I Didn't Know About the ETF Liquidity Illusion While you may believe it's possible to convert ETF assets into cash instantaneously, that's not always the case.
A Little Good News for Tesla's Big Forgotten Product Tesla's Semi is generating serious interest, backed by impressive results -- and potential customers are taking notice.
Great News for Cheniere Energy and LNG Investors The impact of the closure of the Strait of Hormuz won't be short-term, even if it's reopened in 2026.
Crypto Market Today, June 22: Bitcoin Holds Above $64,000 on Easing Geopolitical Tensions Today, June 22, 2026, traders weighed peace talk progress against interest rate concerns and ETF outflows.
Stock Market Today, June 22: Apogee Therapeutics Soars on AbbVie Cash Buyout Offer On June 22, 2026, Apogee Therapeutics shares surged as investors reacted to AbbVie's proposed acquisition terms.
Bio-Rad vs. Charles River Labs: Which Medical Research Stock Is a Better Buy in 2026? Bio-Rad posts robust margins and liquidity, while Charles River leads in global drug discovery services. Explore how their fundamentals stack up for investors.
Stock Market Today, June 22: UiPath Falls as Agentic Automation Push Faces ARR Growth Test UiPath is giving enterprises more ways to coordinate AI agents, robots, and people, with the next readout focused on whether agentic automation demand can lift recurring revenue and customer expansion.
Stock Market Today, June 22: Alphabet Falls as AlphaFold Co-Creator’s Exit Raises AI Talent Concerns Alphabet has the scale to fund AI, with investors looking for Gemini, Google Cloud, and Search to turn that spending into measurable growth as talent concerns intensify.
Stock Market Today, June 22: Alphabet Slips on Key Departure and Defensive Blue Chips Gain On June 22, 2026, investors rotated into blue chips as easing oil prices and diplomatic progress shaped market sentiment, today.
Why CVS Stock Trounced the Market Today It's expanding its scope of services for GLP-1 obesity medications.
Small Cap ETFs from iShares Offer Exciting Growth Opportunities. Is IWO or ISCG the Better Buy? Sector weights and risk profiles differ sharply between these two funds, shaping their appeal for different investor priorities.
Intel Has a Warning for AMD Stock Investors Intel has begun risk production of chips based on a new process node, which could help it prevent further market share losses to AMD.
Why Gold Fields Stock Got Mashed on Monday A media report stated that it might lose control of its largest mine.
Better Buy: SpaceX vs. Intuitive Machines Which of these space stocks has more upside potential?
Marvell Technology vs. Semtech: Which Technology Stock Is a Better Buy in 2026? Marvell's AI infrastructure surge contrasts with Semtech's IoT growth, but each faces unique risks and valuation profiles in the evolving chip landscape.
I Didn't Buy the SpaceX IPO. Here's Why, and What I Bought Instead. SpaceX had a hugely successful IPO, but investors shouldn't ignore this potentially explosive growth play.
Is SCHD a Better Dividend ETF Than VIG? Portfolio size, sector focus, and risk profiles set these two dividend ETFs apart for investors seeking income or growth.
Bitcoin's Been Holding Steady of Late. Is It a Good Buy While It's Around $60,000? The top cryptocurrency hasn't been terribly volatile of late, and that could be an encouraging sign for investors.
3 Reasons to Buy Bristol Myers Squibb Stock Fears about a looming patent cliff have dragged on the shares.
Already Up Around 240% This Year, Is It Too Late to Buy Nebius Stock? Nebius, a fast-growing AI cloud company, has taken off like a rocket this year.
Fidelity or State Street: Which Financial ETF Offers Better Returns? Portfolio depth, liquidity, and yield diverge sharply between these two sector giants—see how their differences could shape your investment strategy.
Late to the Retirement Savings Game? Here's What to Do. Don't panic. You just need to regroup and make some strategic choices.
Can Investing in Microsoft Stock Double Your Money? The tech giant has been struggling this year, but its growth has remained solid, particularly in artificial intelligence.
Upstart's AI Lending Model Faces Its Toughest Test if Rates Stay High The AI-powered lending platform relies on low interest rates to drive its growth.
Arteris COO Sells 39,000 Shares Worth $1.7 Million. Should Investors Worry? Arteris, a provider of semiconductor interconnect IP for advanced chip designs, reported a notable insider sale in its latest SEC filing.
Vanguard ETF Tops iShares Muni Bond on Yield and Cost These two leading bond ETFs take different approaches to balancing stability and returns.
Northern Trust vs. S&P Global: Which Financial Stock Is a Better Buy in 2026? Asset servicing meets financial data dominance as these two industry leaders reveal striking differences in growth, margins, and risk profiles.
What's Wrong With McDonald's Stock? McDonald's stock has fallen 11% this year, and it's now near its 52-week low.
The Dip in Kroger Stock Could Be a Gift. Here's How It Could Set You Up for Life. Kroger's earnings miss grabbed headlines, but the real story with Kroger is the solid investment opportunity investors are overlooking.
Why Rocket Lab Stock Keeps Dropping SpaceX is sucking all the air -- and cash -- out of the space market.
Why Super Micro Computer Stock Is Skyrocketing Today An investment firm thinks that Supermicro stock is poised to soar.
